Methodology of the Field Administration of Stroke Therapy - Magnesium (FAST-MAG) phase 3 trial: Part 1 - rationale and general methods

International Journal of Stroke

Volumn 9, Issue 2, 2014, Pages 215-219

  Saver, Jeffrey L ^a   Starkman, Sidney ^a   Eckstein, Marc ^b   Stratton, Samuel ^c   Pratt, Frank ^a   Hamilton, Scott ^d   Conwit, Robin ^e   Liebeskind, David S ^a   Sung, Gene ^b   Sanossian, Nerses ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Ambulance; Clinical trial; Magnesium; Neuroprotection; Paramedic; Prehospital

Indexed keywords

MAGNESIUM SULFATE; PLACEBO;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; FEASIBILITY STUDY; HUMAN; LOADING DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; STROKE IMPACT SCALE; UNITED STATES; VERY ELDERLY;

AMBULANCE; CLINICAL TRIAL; MAGNESIUM; NEUROPROTECTION; PARAMEDIC; PREHOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; STROKE; TREATMENT OUTCOME;

EID: 84892782300     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12243     Document Type: Article

References (22)

1. Saver JL. Improving reperfusion therapy for acute ischaemic stroke. J Thromb Haemost 2011; 9(Suppl 1):333-343.
2. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the united states: a doubling of treatment rates over the course of 5 years. Stroke 2011; 42:1952-1955.
3. Kidwell CS, Jahan R, Gornbein J etal. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368:914-923.
4. Hassan AE, Chaudhry SA, Grigoryan M, Tekle WG, Qureshi AI. National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era. Stroke 2012; 43:3012-3017.
5. Broderick JP, Palesch YY, Demchuk AM etal. Endovascular therapy after intravenous t-pa versus t-pa alone for stroke. N Engl J Med 2013; 368:893-903.
6. Kidwell CS, Liebeskind DS, Starkman S, Saver JL. Trends in acute ischemic stroke trials through the 20th century. Stroke 2001; 32:1349-1359.
7. Ferguson KN, Kidwell CS, Starkman S, Saver JL. Hyperacute treatment initiation in neuroprotective agent stroke trials. J Stroke Cerebrovasc Dis 2004; 13:109-112.
8. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1, 026 experimental treatments in acute stroke. Ann Neurol 2006; 59:467-477.
9. Saver JL, Starkman S. Magnesium in clinical stroke; in Vink R, Nechifor M (eds): Magnesium in the Central Nervous System. Adelaide, SA, University of Adelaide Press, 2011:205-216.
10. Muir KW. Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness. CNS Drugs 2001; 15:921-930.
11. Bhudia SK, Cosgrove DM, Naugle RI etal. Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 2006; 131:853-861.
12. Mack WJ, Kellner CP, Sahlein DH etal. Intraoperative magnesium infusion during carotid endarterectomy: a double-blind placebo-controlled trial. J Neurosurg 2009; 110:961-967.
13. Longstreth WT Jr, Fahrenbruch CE, Olsufka M, Walsh TR, Copass MK, Cobb LA. Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest. Neurology 2002; 59:506-514.
14. Dubé L, Granry J-C. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anaesth 2003; 50:732-746.
15. Muir KW, Lees KR, Ford I, Davis S. Magnesium for acute stroke (intravenous magnesium efficacy in stroke trial): randomised controlled trial. Lancet 2004; 363:439-445.
16. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy - Magnesium (FAST-MAG) pilot trial. Stroke 2004; 35:e106-108.
17. Silbergleit R, Durkalski V, Lowenstein D etal. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366:591-600.
18. Audebert HJ, Saver JL, Starkman S, Lees KR, Endres M. Prehospital stroke care: new prospects for treatment and clinical research. Neurology 2013; 81:501-508.
19. Ankolekar S, Fuller M, Cross I etal. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in hypertensive stroke trial (RIGHT, ISRCTN66434824). Stroke 2013; 44:3120-3128.
20. Shaw L, Price C, McLure S etal. Paramedic initiated lisinopril for acute stroke treatment (PIL-FAST): results from the pilot randomised controlled trial. Emerg Med J 2013; doi: 10.1136/emermed-2013-202536. [Epub ahead of print].
21. Saver JL, Filip B, Hamilton S etal. Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). Stroke 2010; 41:992-995.
22. Go AS, Mozaffarian D, Roger VL etal. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127:e6-e245.